Qingdao Saber Technology Pharmaceutical: difference between revisions
Diff·revision 11 → 12·01:02, 4 Oct 2025
Difference between revision 11 and revision 12 of Qingdao Saber Technology Pharmaceutical. 2 lines changed; the page grew by 109 bytes.
| Revision 11 — 01:43, 17 Sep 2025 BlankVialBo (talk) add the incorporation year, attributed to the registry record 7,549 bytes ±0 | Revision 12 — 01:02, 4 Oct 2025 IncretinIvo (talk) state the city and province of the registered address 7,658 bytes +109 | ||
|---|---|---|---|
| 19 | }} | 19 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| + | 21 | {{primarysources|date=July 2026|talk=Two organisations, one city, similar names}} | |
| 21 | 22 | ||
| 22 | '''Qingdao Saber Technology Pharmaceutical''' (trading as '''QST'''; qingdaosabertechnology.com) is a research-compound supplier trading as QST from Qingdao, Shandong, China, incorporated in 2017, supplying research peptides, SARMs and raw materials with batch documentation.{{r|registry,selfpub}} | 23 | '''Qingdao Saber Technology Pharmaceutical''' (trading as '''QST'''; qingdaosabertechnology.com) is a research-compound supplier trading as QST from Qingdao, Shandong, China, incorporated in 2017, supplying research peptides, SARMs and raw materials with batch documentation.{{r|registry,selfpub}} |
| ⋮ | ⋮ | ||
| 70 | * [[Peptide content]] | 71 | * [[Peptide content]] |
| 71 | * [[Research use only]] | 72 | * [[Research use only]] |
| + | 73 | * [[Peptide supply chain]] | |
| 72 | 74 | ||
| 73 | {{DEFAULTSORT:Qingdao Saber Technology Pharmaceutical}} | 75 | {{DEFAULTSORT:Qingdao Saber Technology Pharmaceutical}} |